Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Snynf save search
FDA Rejects Regeneron’s Blood Cancer Therapy for Two Forms of Lymphoma
Published: 2024-03-25 (Crawled : 16:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
fda cancer blood therapy
Regeneron Hit With Two CRLs, J&J’s PAH Treatment Approved
Published: 2024-03-25 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
PRGO | $30.515 1.51% 490K
|
Health Technology
|
| O: 0.35%
H: 0.35%
C: -1.34%
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
ABT | News | $107.91 0.78% 1.7M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: 0.0%
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
approved treatment
Biopharma Layoff Tracker 2024: Theratechnologies, GSK, NextCure and More Cut Staff
Published: 2024-03-25 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
RLYB | News | $1.84 3.96% 160K
|
|
| O: 2.5%
H: 1.22%
C: -8.54%
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
VXRT | News | $0.7539 -1.13% 820K
|
Health Technology
|
| O: 1.59%
H: 0.0%
C: -3.91%
TXMD | News | $1.875 -0.27% 13K
|
Health Technology
|
| O: 2.18%
H: 0.0%
C: -2.14%
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
PTCT | News S | $25.66 -1.19% 220K
|
Health Technology
|
| O: -0.31%
H: 2.62%
C: -0.48%
NKTR | News | $1.41 3.68% 710K
|
Health Technology
|
| O: 0.71%
H: 0.83%
C: -3.47%
MOR | News | $17.965 0.03% 150K
|
Health Technology
|
| O: 0.0%
H: 0.22%
C: -0.17%
GLPG | News | $29.67 2.06% 88K
|
Health Technology
|
| O: -0.09%
H: 0.31%
C: -0.15%
AMRN | News | $0.8888 2.67% 560K
|
Health Technology
|
| O: 1.2%
H: 0.99%
C: -3.0%
GOOGL | News S | $158.36 1.33% 13M
|
Technology Services
|
| O: -0.55%
H: 0.29%
C: 0.09%
GOOG | News S | $159.94 1.26% 9.4M
|
Technology Services
|
| O: -0.54%
H: 0.34%
C: 0.13%
OCX | News | $2.46 -1.99% 20K
|
Health Technology
|
| O: -2.08%
H: 0.73%
C: 0.73%
biopharma
Dyne Therapeutics Announces CEO Transition
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
DYN | $26.01 4.58% 450K
|
Health Technology
|
| O: -13.24%
H: 11.02%
C: 6.37%
BIIB | $193.99 -0.06% 660K
|
Health Technology
|
| O: -0.15%
H: 0.23%
C: -0.5%
ceo therapeutics
Regeneron Provides Update on Biologics License Application for Odronextamab
Published: 2024-03-25 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
REGN | News | $910.71 1.17% 150K
|
Health Technology
|
| O: -1.37%
H: 1.15%
C: 0.74%
license update application
Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nods for DMD, Hypertension
Published: 2024-03-22 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
PRGO | $30.515 1.51% 490K
|
Health Technology
|
| O: 0.35%
H: 0.99%
C: -1.17%
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
ABT | News | $107.91 0.78% 1.7M
|
Health Technology
|
| O: -0.43%
H: 0.41%
C: -0.85%
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 1.47%
H: 0.23%
C: -0.19%
fda hypertension
Biopharma Layoff Tracker 2024: GSK, NextCure, Catalent and More Cut Staff
Published: 2024-03-22 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
RLYB | News | $1.84 3.96% 160K
|
|
| O: 2.44%
H: 0.0%
C: -4.76%
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
VXRT | News | $0.7539 -1.13% 820K
|
Health Technology
|
| O: 1.63%
H: 2.4%
C: 0.8%
TXMD | News | $1.875 -0.27% 13K
|
Health Technology
|
| O: 2.61%
H: 1.42%
C: -2.97%
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 1.47%
H: 0.23%
C: -0.19%
PTCT | News S | $25.66 -1.19% 220K
|
Health Technology
|
| O: 0.1%
H: 0.86%
C: -3.68%
NKTR | News | $1.41 3.68% 710K
|
Health Technology
|
| O: 0.3%
H: 2.21%
C: 1.5%
MOR | News | $17.965 0.03% 150K
|
Health Technology
|
| O: 0.94%
H: 0.11%
C: -0.11%
GLPG | News | $29.67 2.06% 88K
|
Health Technology
|
| O: -0.69%
H: 0.15%
C: -1.3%
AMRN | News | $0.8888 2.67% 560K
|
Health Technology
|
| O: 0.2%
H: 4.26%
C: -0.41%
GOOGL | News S | $158.36 1.33% 13M
|
Technology Services
|
| O: 1.03%
H: 1.65%
C: 1.11%
GOOG | News S | $159.94 1.26% 9.4M
|
Technology Services
|
| O: 1.01%
H: 1.54%
C: 1.02%
OCX | News | $2.46 -1.99% 20K
|
Health Technology
|
| O: 0.0%
H: 0.33%
C: 0.33%
biopharma
Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nod for DMD, Hypertension
Published: 2024-03-22 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
PRGO | $30.515 1.51% 490K
|
Health Technology
|
| O: 0.35%
H: 0.99%
C: -1.17%
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
ABT | News | $107.91 0.78% 1.7M
|
Health Technology
|
| O: -0.43%
H: 0.41%
C: -0.85%
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 1.47%
H: 0.23%
C: -0.19%
fda hypertension
Biopharma Layoff Tracker 2024: Catalent, NextCure, Bayer and More Cut Staff
Published: 2024-03-22 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
RLYB | News | $1.84 3.96% 160K
|
|
| O: 2.44%
H: 0.0%
C: -4.76%
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
VXRT | News | $0.7539 -1.13% 820K
|
Health Technology
|
| O: 1.63%
H: 2.4%
C: 0.8%
TXMD | News | $1.875 -0.27% 13K
|
Health Technology
|
| O: 2.61%
H: 1.42%
C: -2.97%
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 1.47%
H: 0.23%
C: -0.19%
PTCT | News S | $25.66 -1.19% 220K
|
Health Technology
|
| O: 0.1%
H: 0.86%
C: -3.68%
NKTR | News | $1.41 3.68% 710K
|
Health Technology
|
| O: 0.3%
H: 2.21%
C: 1.5%
MOR | News | $17.965 0.03% 150K
|
Health Technology
|
| O: 0.94%
H: 0.11%
C: -0.11%
GLPG | News | $29.67 2.06% 88K
|
Health Technology
|
| O: -0.69%
H: 0.15%
C: -1.3%
AMRN | News | $0.8888 2.67% 560K
|
Health Technology
|
| O: 0.2%
H: 4.26%
C: -0.41%
GOOGL | News S | $158.36 1.33% 13M
|
Technology Services
|
| O: 1.03%
H: 1.65%
C: 1.11%
GOOG | News S | $159.94 1.26% 9.4M
|
Technology Services
|
| O: 1.01%
H: 1.54%
C: 1.02%
OCX | News | $2.46 -1.99% 20K
|
Health Technology
|
| O: 0.0%
H: 0.33%
C: 0.33%
biopharma
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
Published: 2024-03-22 (Crawled : 13:30) - globenewswire.com
CUBT | $0.0244 46K
|
n/a
|
| O: 19.3%
H: 0.0%
C: -20.59%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 1.47%
H: 0.23%
C: -0.19%
Press Release: Availability of the Q1 2024 Memorandum for modelling purposes
Published: 2024-03-22 (Crawled : 07:00) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 1.47%
H: 0.23%
C: -0.19%
Iron Drugs Market size to grow by USD 3.55 billion from 2022 to 2027, Technavio
Published: 2024-03-22 (Crawled : 03:00) - prnewswire.com
GLAXF | News | $20.305 630
|
Health Technology
|
| O: -1.71%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
GSK | News | $41.165 1.42% 1.3M
|
Health Technology
|
| O: 0.4%
H: 0.33%
C: -0.45%
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
ABT | News | $107.91 0.78% 1.7M
|
Health Technology
|
| O: -0.43%
H: 0.41%
C: -0.85%
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 1.47%
H: 0.23%
C: -0.19%
market
Biopharma Layoff Tracker 2024: Catalent, Bayer, Spruce and More Cut Staff
Published: 2024-03-21 (Crawled : 17:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
RLYB | News | $1.84 3.96% 160K
|
|
| O: 1.19%
H: 0.0%
C: -3.53%
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
VXRT | News | $0.7539 -1.13% 820K
|
Health Technology
|
| O: 0.0%
H: 2.42%
C: -0.81%
TXMD | News | $1.875 -0.27% 13K
|
Health Technology
|
| O: 0.43%
H: 1.69%
C: -2.54%
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
PTCT | News S | $25.66 -1.19% 220K
|
Health Technology
|
| O: 1.56%
H: 3.25%
C: 0.67%
NKTR | News | $1.41 3.68% 710K
|
Health Technology
|
| O: 1.44%
H: 1.53%
C: -1.72%
MOR | News | $17.965 0.03% 150K
|
Health Technology
|
| O: 0.22%
H: 0.17%
C: -0.22%
GLPG | News | $29.67 2.06% 88K
|
Health Technology
|
| O: -0.97%
H: 0.62%
C: -0.62%
AMRN | News | $0.8888 2.67% 560K
|
Health Technology
|
| O: -0.29%
H: 2.85%
C: -3.68%
GOOGL | News S | $158.36 1.33% 13M
|
Technology Services
|
| O: 0.49%
H: 0.6%
C: -1.25%
GOOG | News S | $159.94 1.26% 9.4M
|
Technology Services
|
| O: 0.43%
H: 0.66%
C: -1.05%
OCX | News | $2.46 -1.99% 20K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -0.65%
biopharma
Mirador Launches with $400M in Funding, Targets Precision Medicines
Published: 2024-03-21 (Crawled : 15:30) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
precision
MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor
Published: 2024-03-21 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
pharmaceuticals
Biopharma Layoff Tracker 2024: Bayer, Spruce, Takeda and More Cut Staff
Published: 2024-03-21 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
RLYB | News | $1.84 3.96% 160K
|
|
| O: 1.19%
H: 0.0%
C: -3.53%
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
VXRT | News | $0.7539 -1.13% 820K
|
Health Technology
|
| O: 0.0%
H: 2.42%
C: -0.81%
TXMD | News | $1.875 -0.27% 13K
|
Health Technology
|
| O: 0.43%
H: 1.69%
C: -2.54%
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
PTCT | News S | $25.66 -1.19% 220K
|
Health Technology
|
| O: 1.56%
H: 3.25%
C: 0.67%
NKTR | News | $1.41 3.68% 710K
|
Health Technology
|
| O: 1.44%
H: 1.53%
C: -1.72%
MOR | News | $17.965 0.03% 150K
|
Health Technology
|
| O: 0.22%
H: 0.17%
C: -0.22%
GLPG | News | $29.67 2.06% 88K
|
Health Technology
|
| O: -0.97%
H: 0.62%
C: -0.62%
AMRN | News | $0.8888 2.67% 560K
|
Health Technology
|
| O: -0.29%
H: 2.85%
C: -3.68%
GOOGL | News S | $158.36 1.33% 13M
|
Technology Services
|
| O: 0.49%
H: 0.6%
C: -1.25%
GOOG | News S | $159.94 1.26% 9.4M
|
Technology Services
|
| O: 0.43%
H: 0.66%
C: -1.05%
OCX | News | $2.46 -1.99% 20K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -0.65%
takeda biopharma
FDA Approves Takeda’s Iclusig for Type of Leukemia, Idorsia’s Hypertension Drug
Published: 2024-03-21 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
PRGO | $30.515 1.51% 490K
|
Health Technology
|
| O: 0.0%
H: 1.6%
C: 0.89%
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
ABT | News | $107.91 0.78% 1.7M
|
Health Technology
|
| O: -0.56%
H: 0.0%
C: 0.0%
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
fda drug iclusig hypertension
Exscientia Business and Financial Update for the Full Year 2023
Published: 2024-03-21 (Crawled : 13:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
EXAI | $4.42 4.0% 260K
|
|
| O: -3.35%
H: 0.0%
C: -7.39%
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
business year update financial
Mirador Therapeutics Launches to Accelerate the Next Generation of Precision Medicines for Immune-mediated Diseases
Published: 2024-03-21 (Crawled : 12:30) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
precision therapeutics
CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors
Published: 2024-03-21 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
CTMX | $1.68 0.6% 140K
|
Health Technology
|
| O: -1.76%
H: 3.59%
C: 0.45%
therapeutics
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.56 162.07% 21M
|
AGBA | $2.74 119.2% 52M
|
Finance
CZOO | $9.07 81.76% 22M
|
EDBL | News | $6.56 74.47% 1.8M
|
MTC | $2.21 41.67% 5.6M
|
Technology Services
OPRT | News | $3.12 38.67% 11M
|
Finance
PALI | $6.59 33.67% 23M
|
Manufacturing
VNRX | $0.7945 32.42% 3.1M
|
Health Technology
MLEC | $1.81 29.29% 2.8M
|
n/a
BTCM | $3.45 27.78% 640K
|
Arts, Entertainment, and Recrea...
Your saved searches
Save your searches and get alerts when important news are released.